Search results
US FDA chief very concerned about fake weight loss drugs
Reuters via Yahoo News· 3 months agoNEW YORK (Reuters) -U.S. Food and Drug Administration Commissioner Dr. Robert Califf said on...
Musk says Twitter to soon enable organizations to identify their associated accounts
Reuters via Yahoo Finance· 2 years ago(Reuters) - Twitter's billionaire owner Elon Musk on Sunday said that Twitter will soon enable...
RSV cases in US show signs of return to pre-pandemic seasonality: CDC
Reuters via Yahoo Finance· 1 year agoRespiratory syncytial virus (RSV) circulation is showing signs of return to pre-pandemic seasonality...
FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern
Reuters via Yahoo News· 1 year agoWall Street analysts said Dunn's departure could impact the regulator's stance on neurological drug...
U.S. sets $1.74 billion deal with Moderna for updated COVID vaccine
Reuters via Yahoo News· 2 years agoCombined with 105 million doses the government already agreed to buy from Pfizer Inc and partner...
U.S. FDA calls for new regulatory framework for use of cannabis compound CBD
Reuters via Yahoo News· 1 year agoThe health regulator said it would work with Congress to develop a new, cross-agency regulatory...
CVS raises annual COVID-related revenue forecast to $3 billion
Reuters via Yahoo Finance· 2 years agoCVS Health Corp on Wednesday lifted its annual outlook for COVID-19-related revenue as it expects...
UPDATE 2-CVS in advanced talks to buy Signify Health for about $8 bln -source
Reuters via Yahoo Finance· 2 years agoDrugstore chain owner CVS Health Corp is in advanced talks to buy home-healthcare company Signify Health Inc for about $8 billion, according to a person familiar with the matter. CVS is close ...
U.S. adds 2.5 million Bavarian Nordic monkeypox vaccine doses, expects more in July
Reuters via Yahoo News· 2 years agoSo far, 1,470 cases of monkeypox, which can cause flu-like symptoms and skin lesions, have been...
U.S. FDA approves Amylyx ALS drug
Reuters via Yahoo Finance· 2 years agoSept 29(Reuters) - The U.S. Food and Drug Administration on Thursday approved Amylyx Pharmaceuticals Inc's drug for slowing progression of ALS, or amyotrophic lateral sclerosis, and potentially ...
